GlassScriptPhysician profile
Regina Husman
NPI 1033748330
$4,480.78
in general payments reported to CMS, 2019-2025
12 companies · $3,985 in 2025
The $3,985 reported for 2025 was more than what 82% of Vascular Surgery providers received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $169 · 2023: $194 · 2024: $133 · 2025: $3,985.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,548 · Travel and Lodging: $1,437.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,547.71 |
| Travel and Lodging | $1,437.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,550.42 | 2025 | Perclose Proglide, Esprit, Supera |
| Boston Scientific Corporation | $405.45 | 2025 | General - Vascular Intervention, Enroute Transcarotid Stent, Varithena Administration Pack |
| W. L. Gore & Associates, INC. | $280.92 | 2025 | Gore Tag Conformable Thoracic Endoprosthesis, Gore Excluder Thoracoabdominal Branch Endoprosthesis, Gore Excluder Iliac Branch Endoprosthesis |
| Angiodynamics, INC. | $250.57 | 2025 | Alphavac, Auryon Laser System 100-120 Vac |
| Cook Medical LLC | $150.22 | 2025 | Icast Covered Stent System, 6mmx22mmx120cm |
| Lemaitre Vascular, INC. | $128.41 | 2025 | Artegraft Vascular Graft, Hydro Lemaitre Valvulotome, Restoreflow |
| Endologix LLC | $55.44 | 2025 | Torus Stent Graft System, Endocross Device |
| Medtronic, INC. | $51.83 | 2025 | Venaseal, Plasmablade(Tm) |
| Baxter Healthcare | $35.60 | 2025 | Perclot |
| Acera Surgical, INC. | $29.99 | 2025 | Restrata Wound Matrix |
| Bayer Healthcare Pharmaceuticals INC. | $29.30 | 2025 | |
| Novo Nordisk INC | $17.01 | 2025 | Wegovy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Regina Husman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.